Access to the 340B Drug Pricing Program: is there evidence of strategic hospital behavior?

The 340B Drug Pricing Program allows hospitals to purchase covered drugs at a discount and potentially generate profit if they are reimbursed at rates that exceed 340B acquisition prices. Disproportionate shar...

Source: BMC Research Notes - June 3, 2021 Category: Research Authors: Karen Mulligan, John A. Romley and Rebecca Myerson Tags: Research note Source Type: research